Steve Nicolle brings new outlook to Nova Scotia's Life Sciences Sector
HALIFAX, Sept. 12, 2013 /CNW/ - STI, the leader in intelligent
reimbursement solutions for the Canadian healthcare market, is pleased
to announce the appointment of STI CEO, Steve Nicolle, to the BioNova
Board of Directors.
The executive of the Halifax-based company joined the local life
sciences organization in late August, bringing with him ten years of
CEO and Board-level experience at New England venture-backed technology
companies, in addition to his knowledge and experience in his CEO role
at STI since 2010.
"We are pleased to welcome Steve to the BioNova Board," says Marli
MacNeil, CEO of BioNova. "Steve's background and current position with
STI will allow him to bring a unique perspective to the Board."
STI has a proven reputation in the life sciences community of bringing
innovation to BioTech companies; their customers include the major
pharmaceutical manufacturers in Canada. Founded in 2002, they have been
an influential solution provider to the Canadian pharmaceutical
industry for over the past ten years.
"We seldom find a CEO who commands instant credibility and trust from
international venture capital and strategic investors, Steve has that
unique ability," says Brian Bloom, President at Bloom Burton & Co. "We
think this is a great opportunity for Nova Scotia to benefit from his
experience, knowledge and approach to getting things done."
SOURCE: STI Technologies Limited
For further information:
Mary Jane Leslie